Clinical Trial Update: The Utility of Nexium in Chronic Cough and Reflux Disease [Phase 4]

View source ↗

Summary

A Phase 4 study assessed the utility of esomeprazole (Nexium) for chronic cough and gastroesophageal reflux disease; the trial is completed and results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough
• Gastroesophageal Reflux Disease

Drugs mentioned

• Nexium (esomeprazole)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Cough, GERD | Phase 4 | Status: COMPLETED | Results posted: 2011-06-02